Incannex Wrapping Up US Phase 2 Trial for Dual-Mechanism OSA Drug Candidate
Top-line results are expected later this month.
Read MoreTop-line results are expected later this month.
Read MoreThe new arrival is a nasal pillows interface.
Read MoreIt streamlines the implant procedure by eliminating the need for a separate sensing lead.
Read MoreAlkermes today released topline results from the randomized double-blind treatment period of the Vibrance-1 phase 2 study evaluating alixorexton in patients with narcolepsy type 1.
Read MoreIt builds on the organization’s commitment to translating sleep science and insight into practical, actionable guidance.
Read More